- Home
- IMMX vs NICK Comparison
IMMX vs NICK Comparison
Compare IMMX & NICK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- NICK
- Stock Information
- Founded
- IMMX 2014
- NICK 1985
- Country
- IMMX United States
- NICK United States
- Employees
- IMMX N/A
- NICK N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- NICK
- Sector
- IMMX Health Care
- NICK
- Exchange
- IMMX Nasdaq
- NICK Nasdaq
- Market Cap
- IMMX 51.1M
- NICK 44.7M
- IPO Year
- IMMX 2021
- NICK 1997
- Fundamental
- Price
- IMMX $1.66
- NICK $6.20
- Analyst Decision
- IMMX Strong Buy
- NICK
- Analyst Count
- IMMX 1
- NICK 0
- Target Price
- IMMX $7.00
- NICK N/A
- AVG Volume (30 Days)
- IMMX 108.3K
- NICK 11.1K
- Earning Date
- IMMX 11-11-2024
- NICK 11-12-2024
- Dividend Yield
- IMMX N/A
- NICK N/A
- EPS Growth
- IMMX N/A
- NICK N/A
- EPS
- IMMX N/A
- NICK N/A
- Revenue
- IMMX N/A
- NICK $19,227,000.00
- Revenue This Year
- IMMX N/A
- NICK N/A
- Revenue Next Year
- IMMX $200.00
- NICK N/A
- P/E Ratio
- IMMX N/A
- NICK N/A
- Revenue Growth
- IMMX N/A
- NICK N/A
- 52 Week Low
- IMMX $1.26
- NICK $4.37
- 52 Week High
- IMMX $7.75
- NICK $7.55
- Technical
- Relative Strength Index (RSI)
- IMMX 45.76
- NICK 51.65
- Support Level
- IMMX $1.43
- NICK $5.98
- Resistance Level
- IMMX $1.94
- NICK $6.54
- Average True Range (ATR)
- IMMX 0.13
- NICK 0.27
- MACD
- IMMX -0.01
- NICK 0.01
- Stochastic Oscillator
- IMMX 57.97
- NICK 31.25
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About NICK Nicholas Financial Inc.
Nicholas Financial Inc is a specialized consumer finance company. It is engaged in acquiring and servicing automobile finance installment contracts for purchases of used and new automobiles and light trucks. It also originates direct consumer loans and sells consumer-finance-related products. The majority of its revenue comes from Interest and fee income.